Projects

“SafeBoosC IIIv - Cerebral oximetry versus standard care in newborns receiving invasive mechanical ventilation – an RCT

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 65535

Project Lead

Authors

Shashidhar, Dr. Soudamini, Dr. Nalina A, Dr. Shubha AM, Dr. Rajkiran Raju S.

Project Status

ongoing